CH621940A5 - Process for the production of a pharmaceutical composition with delayed release of active ingredient - Google Patents

Process for the production of a pharmaceutical composition with delayed release of active ingredient Download PDF

Info

Publication number
CH621940A5
CH621940A5 CH1090876A CH1090876A CH621940A5 CH 621940 A5 CH621940 A5 CH 621940A5 CH 1090876 A CH1090876 A CH 1090876A CH 1090876 A CH1090876 A CH 1090876A CH 621940 A5 CH621940 A5 CH 621940A5
Authority
CH
Switzerland
Prior art keywords
polymer
salt
solution
pilocarpine
acid
Prior art date
Application number
CH1090876A
Other languages
German (de)
English (en)
Inventor
Izhak Dr Blank
Joseph Fertig
Original Assignee
Hydrophilics Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB3529575A external-priority patent/GB1563390A/en
Application filed by Hydrophilics Int Inc filed Critical Hydrophilics Int Inc
Publication of CH621940A5 publication Critical patent/CH621940A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1090876A 1975-08-27 1976-08-27 Process for the production of a pharmaceutical composition with delayed release of active ingredient CH621940A5 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB3529575A GB1563390A (en) 1975-08-27 1975-08-27 Pharmaceutical products
GB3529675 1975-08-27
GB2396376 1976-06-10
GB2396276 1976-06-10

Publications (1)

Publication Number Publication Date
CH621940A5 true CH621940A5 (en) 1981-03-13

Family

ID=27448608

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1090876A CH621940A5 (en) 1975-08-27 1976-08-27 Process for the production of a pharmaceutical composition with delayed release of active ingredient

Country Status (5)

Country Link
JP (1) JPS5254014A (sv)
CH (1) CH621940A5 (sv)
DE (1) DE2636559C2 (sv)
IL (1) IL50250A (sv)
SE (1) SE7609339L (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
GB2013084B (en) * 1978-01-25 1982-07-28 Alcon Lab Inc Ophthalmic drug dosage
HU187313B (en) * 1980-10-03 1985-12-28 Andras Sugar Dental cosmetic prparation
IL61721A (en) * 1980-12-16 1984-03-30 Blank Izhak Nitroglycerin preparations
US4539199A (en) * 1981-01-14 1985-09-03 Egyt Gyogyszervegyeszeti Gyar Sustained release pharmaceutical compositions
EP0103970A3 (en) * 1982-08-20 1985-05-22 LAWRENCE, Peter Robin Broughton Amine salts and products containing them
AU563054B2 (en) * 1984-10-24 1987-06-25 Sekisui Kagaku Kogyo Kabushiki Kaisha Percutaneous tape of isdn
CA1295941C (en) * 1985-08-16 1992-02-18 Rajan Bawa Sustained-release formulation comprising a hydrophobic polymer system
EP0268680A4 (de) * 1986-05-29 1990-04-10 Vnii Ispytatel Med Tech Antitumorfilm aus biologisch abbaubaren polymeren.
DE19508029C2 (de) * 1995-03-07 1997-10-09 Richard Prof Dr Sueverkruep Darreichungsform zur äußerlichen Applikation von ophthalmischen Arzneistoffen und Verfahren zur Herstellung derselben
US5972326A (en) * 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye
US5888494A (en) * 1996-03-12 1999-03-30 Adolor Corporation Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith
DE59707744D1 (de) * 1996-10-23 2002-08-22 Sueddeutsche Kalkstickstoff Verfahren zur herstellung von biologisch aktiven polymernanopartikel-nucleinsäure-konjugaten
DE19753298A1 (de) * 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DK172900B1 (da) * 1998-12-18 1999-09-27 Per Julius Nielsen Præparat samt kit til brug ved intraoculære operationer
KR101311134B1 (ko) * 2011-03-18 2013-09-25 가부시키가이샤 시드 약물 서방성 의료용 디바이스
JP2017080303A (ja) * 2015-10-30 2017-05-18 日油株式会社 薬物徐放性医療用コンタクトレンズ
BR112020009361A2 (pt) 2017-11-17 2020-10-13 Cellix Bio Private Limited composto de fórmula i, composição farmacêutica para tratar um distúrbio ocular ou complicações do mesmo, método de síntese de composto, método de tratamento de um distúrbio ocular ou complicações do mesmo em um indivíduo que precisa do mesmo e uso de um composto

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2229984A1 (de) * 1972-06-20 1974-01-10 Kraemer Kg Wilhelm Befestigungsvorrichtung fuer eine batteriegespeiste warnleuchte
DE2246037B2 (de) * 1972-09-20 1975-02-27 Taeschner & Co, 8831 Kipfenberg Peroral anwendbares Arzneimittel mit verzögerter Resorbierbarkeit in Suspensionsform

Also Published As

Publication number Publication date
IL50250A0 (en) 1976-10-31
JPS5254014A (en) 1977-05-02
SE7609339L (sv) 1977-02-28
DE2636559C2 (de) 1985-10-31
DE2636559A1 (de) 1977-03-17
IL50250A (en) 1980-01-31

Similar Documents

Publication Publication Date Title
US4248855A (en) Pharmaceutical base salts
CH621940A5 (en) Process for the production of a pharmaceutical composition with delayed release of active ingredient
DE69233327T2 (de) Oxycodonhaltige Arzneizusammensetzungen mit verzögerter Wirkstoffabgabe
DE69732049T2 (de) Pharmazeutische zubereitungen, enthaltend salze von hyaluronsäure und lokalanästhetika
DE69828993T2 (de) Kontrollierte abgabe von pharmazeutika in der vorderen augenkammer
DE2908847C3 (de) Pharmazeutische Zubereitung mit verzögerter Freigabe
DE60112772T2 (de) Suppositorien die im unteren rectum zurückgehalten werden
DE60201134T2 (de) Zusammenstetzung zur transdermalen Abgabe von Nikotin zum Einstellen des Rauchens
DE2523998A1 (de) Pharmazeutische zubereitung fuer die behandlung der schizophrenie
DE2721603A1 (de) Beschichtete koernchen aus alkalimetallsalzen der polyacrylsaeure und verfahren zu ihrer herstellung
DE3400106A1 (de) Pharmazeutische zubereitungen mit gesteuerter arzneistoff-freisetzung
DE2902863C2 (de) Wäßriges Gel zur Anwendung im Bindehautsack, enthaltent Pilocarpin und Ethylenmaleinsäureanhydridpolymer
DE60033044T2 (de) Zusammensetzung von morphin methansulphonat und chitosan zur nasalen verabreicherung
DE1088192B (de) Verfahren zur Herstellung von tablettierbaren oder direkt verwendbaren Arzneimittelgranulaten mit einstellbaren Freigabeeigenschaften
CH639560A5 (en) Pharmaceutical preparation having a prolonged uniform active compound release
DE10132876A1 (de) Zweiphasige, tropfbare Hydrogele zur Anwendung am Auge
EP0469440A1 (de) Feste orale Applikationsformen, die als Wirkstoff Ifosfamid enthalten
DE1944694C3 (de) Pharmazeutische Zubereitung
DE2937489A1 (de) Arzneimittel zur behandlung hypertoner funktionszustaende der harnblase
DE1944693B2 (de) Pharmazeutische zubereitung
DE1925919A1 (de) Arzneimittelzubereitung mit gleichmaessiger Arzneifreigabe
GB1563390A (en) Pharmaceutical products
EP1458389B1 (de) Wässrige lösungen von moxaverin zur behandlung der erektilen dysfunktion
DE2802114A1 (de) Neue pharmazeutische zusammensetzung und verfahren zu deren herstellung
DE4023136A1 (de) Neue galenische, orale form zur verbesserung der bioverfuegbarkeit von medikamenten

Legal Events

Date Code Title Description
PL Patent ceased